Dana Vigier MD

Dana Vigier, Regional Vice President at Alexion, AstraZeneca Rare Disease, blends clinical training as a French general practitioner with broad pharmaceutical leadership experience. Formerly President of the French Pharma Association in Oncology and a Global Franchise leader at AstraZeneca, she now oversees Alexion’s operations across Central and Northern Europe, including Switzerland, the Netherlands, the four Nordic countries, and Austria. In this role, Vigier has identified critical systemic inequities in rare disease access that transcend national wealth, advocating for fundamental reforms to healthcare frameworks and value assessment methodologies.